Literature DB >> 10388974

Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.

J B Ruige1, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter, R J Heine.   

Abstract

OBJECTIVE: Leptin is thought to play a key role in the control of body weight. There is a complex interrelationship between leptin and insulin or insulin resistance, but it is unknown how leptin is regulated. We therefore explored, in a large population-based study of 2,484 Caucasian subjects aged 50-74 years, the relationship between leptin and variables of body adiposity, energy balance, and insulin resistance. RESEARCH DESIGN AND METHODS: Leptin was measured by means of a radioimmunoassay. Multiple linear regression analyses were performed with leptin as dependent variable and age, sex, BMI, waist circumference, daily energy intake, physical activity, smoking, hypertension, fasting triglyceride concentrations, HDL cholesterol, fasting plasma glucose, and fasting plasma insulin concentrations as independent variables (determinants)
RESULTS: Leptin concentrations were found to be four times higher in women than in men. Effect modification between sex and potential determinants was expected, and the analyses were performed separately for women and men. BMI was the strongest determinant of leptin in women and waist circumference the strongest determinant in men. BMI, waist circumference, insulin, and triglyceride concentrations were independently and significantly (P < 0.05) associated with leptin, while inverse associations were shown for smoking and daily energy intake (borderline significance).
CONCLUSIONS: This study confirms the relationship between insulin and leptin and, in addition, suggests a relationship between triglyceride concentrations and leptin independent of sex, BMI, waist circumference, and insulin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388974     DOI: 10.2337/diacare.22.7.1097

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  20 in total

1.  Comment on: Schmidt MI, Duncan BB, Vigo A et al (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086-2096.

Authors:  M B Snijder; J M Dekker; L M Bouter; R J Heine; C D A Stehouwer; J C Seidell
Journal:  Diabetologia       Date:  2006-10-11       Impact factor: 10.122

Review 2.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

3.  Correlates of leptin in children with chronic kidney disease.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2014-07-25       Impact factor: 4.406

Review 4.  Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes?

Authors:  Milagros Gloria Huerta
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

5.  A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans.

Authors:  R Duggirala; J Blangero; L Almasy; R Arya; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern
Journal:  Am J Hum Genet       Date:  2001-03-29       Impact factor: 11.025

6.  Leptin as a Predictive Marker in Unexplained Infertility in North Indian Population.

Authors:  Pratibha Kumari; S P Jaiswar; Pushplata Shankhwar; Sujata Deo; Kalim Ahmad; Bushra Iqbal; A A Mahdi
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

Review 8.  Olive oil consumption and non-alcoholic fatty liver disease.

Authors:  Nimer Assy; Faris Nassar; Gattas Nasser; Maria Grosovski
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

9.  Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance.

Authors:  Cari M Kitahara; Britton Trabert; Hormuzd A Katki; Anil K Chaturvedi; Troy J Kemp; Ligia A Pinto; Steven C Moore; Mark P Purdue; Nicolas Wentzensen; Allan Hildesheim; Meredith S Shiels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-09-23       Impact factor: 4.254

Review 10.  Progress and controversies: treating obesity and insulin resistance in the context of hypertension.

Authors:  Janet B McGill; Steven Haffner; Tomas J Rees; James R Sowers; Andrew M Tershakovec; Michael Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.